1. Home
  2. LEDS vs LPCN Comparison

LEDS vs LPCN Comparison

Compare LEDS & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

N/A

Current Price

$2.02

Market Cap

18.4M

Sector

Technology

ML Signal

N/A

Logo Lipocine Inc.

LPCN

Lipocine Inc.

N/A

Current Price

$1.43

Market Cap

18.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LEDS
LPCN
Founded
2005
1997
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
18.7M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
LEDS
LPCN
Price
$2.02
$1.43
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
8.1K
★ 1.6M
Earning Date
11-27-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 53.12
N/A
EPS
★ 0.02
N/A
Revenue
★ $43,009,000.00
$1,976,677.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.02
P/E Ratio
$107.50
★ N/A
Revenue Growth
★ 729.81
N/A
52 Week Low
$1.01
$1.40
52 Week High
$3.62
$12.37

Technical Indicators

Market Signals
Indicator
LEDS
LPCN
Relative Strength Index (RSI) 45.45 30.05
Support Level $1.85 N/A
Resistance Level $2.45 $2.50
Average True Range (ATR) 0.09 0.11
MACD 0.00 -0.00
Stochastic Oscillator 50.00 9.12

Price Performance

Historical Comparison
LEDS
LPCN

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates, or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy (TRT). It also has other products in the pipeline, such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: